Literature DB >> 9427479

Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response.

G D Cappon1, L L Morford, C V Vorhees.   

Abstract

Methamphetamine (MA) administration to adult rats results in neurotoxicity characterized by depletion of caudate-putamen (CP) dopamine (DA) and serotonin (5-HT) and an accompanying increase in glial fibrillary acidic protein (GFAP) content. The severity of MA-induced neurotoxicity correlates with the accompanying thermoregulatory response, i.e., a hyperthermic response facilitates neurotoxicity while a hypothermic response is neuroprotective. In the following study, the thermoregulatory and neurotoxic effects of MA administration (4 x 10 mg/kg) were investigated in developing rats at postnatal days (PND) 20, 40 and 60. Rats at PND 20 and PND 40 were administered MA at ambient temperatures of 22 degrees C and 30 degrees C; and PND 60 rats were administered MA at 22 degrees C only. Temperatures were measured and thermal responses were compared by calculating the total thermal response (TTR) induced by MA treatment. MA administration to PND 60 rats at 22 degrees C induced a hyperthermic response, resulted in a 47% reduction of neostriatal DA and a 49% increase of GFAP content. Administration of MA to PND 40 rats at 22 degrees C failed to induce a hyperthermic response and did not result in reduced DA or increased GFAP. However, administration of MA to PND 40 rats at 30 degrees C induced hyperthermia, reduced neostriatal DA by 54% and increased GFAP by 70%. MA administration to PND 20 rats at either 22 degrees C or 30 degrees C did not result in DA depletion or increased GFAP, even though MA administration to PND 20 rats at 30 degrees C induced hyperthermia. These results demonstrate that the induction of hyperthermia is necessary to exhibit MA-induced neurotoxicity at PND 40; however, PND 20 rats are resistant to the DA depleting effects of MA despite the induction of hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427479     DOI: 10.1016/s0165-3806(97)81791-9

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  31 in total

1.  Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.

Authors:  T Xie; U D McCann; S Kim; J Yuan; G A Ricaurte
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Differential effects of psychoactive drugs in adolescents and adults.

Authors:  Sari Izenwasser
Journal:  Crit Rev Neurobiol       Date:  2005

3.  Cockayne syndrome B protects against methamphetamine-enhanced oxidative DNA damage in murine fetal brain and postnatal neurodevelopmental deficits.

Authors:  Gordon P McCallum; Andrea W Wong; Peter G Wells
Journal:  Antioxid Redox Signal       Date:  2011-01-05       Impact factor: 8.401

4.  Glial reactivity in resistance to methamphetamine-induced neurotoxicity.

Authors:  Danielle M Friend; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-03-17       Impact factor: 5.372

5.  Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

6.  Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.

Authors:  Michael T Williams; Nicole R Herring; Tori L Schaefer; Matthew R Skelton; Nicholas G Campbell; Jack W Lipton; Anne E McCrea; Charles V Vorhees
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

Review 7.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017

8.  Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats.

Authors:  Elena Zakharova; Giorgia Leoni; Ilona Kichko; Sari Izenwasser
Journal:  Behav Brain Res       Date:  2008-10-18       Impact factor: 3.332

Review 9.  Behavioral pharmacology of designer cathinones: a review of the preclinical literature.

Authors:  Ryan A Gregg; Scott M Rawls
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

10.  Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits.

Authors:  Andrea W Wong; Gordon P McCallum; Winnie Jeng; Peter G Wells
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.